Oisin Biotechnologies
Latest round
- Series A
Last raised
- Jun 2024
Total raised
- $10M
Investors
- 2
About Oisin Biotechnologies
Founded in 2014 in Seattle, US, Oisin Biotechnologies is dedicated to creating genetic therapies aimed at age-related health issues. The firm has completed 3 deals to date, with its most recent deal occurring on June 28, 2024.Oisin Biotechnologies specializes in pioneering genetic medicines designed to address age-related conditions. Highlighting their offerings is the patented Fusogenix™ Proteo-Lipid Vehicle (PLV), a non-viral delivery system that enhances the distribution of DNA and RNA payloads.Oisin Biotechnologies generates revenue through partnerships and collaborations with health and pharmaceutical organizations, focusing on B2B transactions. Their model includes licensing agreements and research collaborations, allowing clients access to proprietary technologies and therapeutic programs.38 mn, Oisin Biotechnologies plans to advance its treatments for age-related diseases towards human trials. The company is set to explore new markets in both Europe and Asia, aiming for expansion by 2025.
Who invested in Oisin Biotechnologies
2 investors across 2 rounds
See all investors in Oisin Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Oisin Biotechnologies
Who invested in Oisin Biotechnologies?
Oisin Biotechnologies has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oisin Biotechnologies raised?
Oisin Biotechnologies has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Oisin Biotechnologies last raise money?
Oisin Biotechnologies's most recent round on record is a Series A, in Jun 2024.
What does Oisin Biotechnologies do?
Founded in 2014 in Seattle, US, Oisin Biotechnologies is dedicated to creating genetic therapies aimed at age-related health issues.
Where is Oisin Biotechnologies headquartered?
Oisin Biotechnologies is headquartered in Seattle, US.
Which VCs invest in companies like Oisin Biotechnologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Oisin Biotechnologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Oisin Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.